INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10
Wei ZhangiD, Jinjing Zhao, Lin DengiD, Nestor IshimweiD, Jessica PauliiD, Wen WuiD, Shengshuai ShaniD, Wolfgang Kempf, Margaret D. Ballantyne, David S. KimiD, Qing LyuiD, Matthew BennettiD, Julie RodoriD, Adam W. TurneriD, Yao Wei LuiD, Ping Ting GaoiD, Mihyun ChoiiD, Ganesh WarthiiD, Ha Won KimiD, Margarida BarrosoiD, William Bart BryantiD, Clint L. MilleriD, Neal L. WeintraubiD, Lars MäegdefesseliD, Joseph M. MianoiD, , Xiaochun LongiD
Abstract
BackgroundActivation of vascular smooth muscle cells (VSMCs) inflammation is vital to initiate vascular disease. However, the role of human-specific long noncoding RNAs (lncRNAs) in VSMC inflammation is poorly understood. MethodsBulk RNA-seq in differentiated human VSMCs revealed a novel human-specific lncRNA called INflammatory MKL1 Interacting Long Noncoding RNA (INKILN). INKILN expression was assessed in multiple in vitro and ex vivo models of VSMC phenotypic modulation and human atherosclerosis and abdominal aortic aneurysm (AAA) samples. The transcriptional regulation of INKILN was determined through luciferase reporter system and chromatin immunoprecipitation assay. Both loss- and gain-of-function approaches and multiple RNA-protein and protein-protein interaction assays were utilized to uncover the role of INKILN in VSMC proinflammatory gene program and underlying mechanisms. Bacterial Artificial Chromosome (BAC) transgenic (Tg) mice were utilized to study INKLIN expression and function in ligation injury-induced neointimal formation. ResultsINKILN expression is downregulated in contractile VSMCs and induced by human atherosclerosis and abdominal aortic aneurysm. INKILN is transcriptionally activated by the p65 pathway, partially through a predicted NF-{kappa}B site within its proximal promoter. INKILN activates the proinflammatory gene expression in cultured human VSMCs and ex vivo cultured vessels. Mechanistically, INKILN physically interacts with and stabilizes MKL1, a key activator of VSMC inflammation through the p65/NF-{kappa}B pathway. INKILN depletion blocks ILI{beta}-induced nuclear localization of both p65 and MKL1. Knockdown of INKILN abolishes the physical interaction between p65 and MKL1, and the luciferase activity of an NF-{kappa}B reporter. Further, INKILN knockdown enhances MKL1 ubiquitination, likely through the reduced physical interaction with the deubiquitinating enzyme, USP10. INKILN is induced in injured carotid arteries and exacerbates ligation injury-induced neointimal formation in BAC Tg mice. ConclusionsThese findings elucidate an important pathway of VSMC inflammation involving an INKILN/MKL1/USP10 regulatory axis. Human BAC Tg mice offer a novel and physiologically relevant approach for investigating human-specific lncRNAs under vascular disease conditions.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 69
- FWCI
- 7.53
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A regulatory role of novel long non-coding RNA, BAZ1A-AS1, in vascular smooth muscle cell functions during neointima formation in human saphenous veins
David S. Kim, Brandee M. S. S. Goo, … Neal L Weintraub·bioRxiv·May 11, 2026
- Lkb1 is a master regulator of VSMC fate and function in mice
- Loss of physiological stretch elicits an inflammatory, plaque-like transcriptional state in cultured human aortic smooth muscle cells
Lise Filt Jensen, Anton Markov, … Julián Albarrán-Juárez·bioRxiv·Oct 29, 2025
- NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1high smooth muscle cells in atherosclerotic lesions
Xiao-Ying Zhang, Xintong Jiang, … Maria E. Johansson·AtherosclerosisPeer-reviewed·May 24, 2026
- Selective role of Nck1 in atherogenic inflammation and plaque formation
M. Alfaidi, C. H. Acosta, … A. W. Orr·bioRxiv·Apr 6, 2020
- Myogenic anti-nucleolin aptamer iSN04 inhibits proliferation and promotes differentiation of vascular smooth muscle cells
Mana Miyoshi, Takeshi Shimosato, Tomohide Takaya·BiomoleculesPeer-reviewed·Jun 15, 2024